Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 34, pseudogene (RNU1-34P) is a pseudogene that belongs to the family of U1 small nuclear RNAs (snRNAs) [2][4]. U1 snRNAs are essential, highly conserved non-coding RNAs that play a central role in pre-mRNA splicing by recognizing the 5’ splice site and forming a component of the spliceosomal U1 small nuclear ribonucleoprotein (snRNP) complex [1][6]. However, as a pseudogene, RNU1-34P is generally considered a non-functional genomic locus that arose from a duplication of a functional U1 snRNA gene but has lost its ability to produce a functional snRNA transcript, due to accumulations of mutations or deletions [4][2]. There is no evidence that RNU1-34P participates in any cellular process, encodes a functional product, or serves as a therapeutic target. Information and gene records exist for RNU1-34P due to its sequence homology and annotation as a U1 snRNA family member, but its designation as a pseudogene means it is not expected to play a direct biological role [4][2][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 34, pseudogene (RNU1-34P).